Partners names interim CEO

Alyssa Rege - Print  | 

Partners HealthCare named an interim successor to David Torchiana, MD, who plans to resign from his position as president and CEO of the system in April.

The Boston-based health system's board of directors named Anne Klibanski, MD, interim chief executive on Feb. 18. Dr. Klibanski has served as Partners' chief academic officer since 2012 and serves as the chief of neuroendocrine at Boston-based Massachusetts General Hospital.

"Anne is one of our most experienced senior leaders as well as a distinguished clinician, researcher and teacher. She has broad responsibility for many of our key missions and is a proven leader and manager of complex efforts with extensive experience overseeing large clinical and executive teams, crafting a systemwide approach to future state radiology, pathology and anesthesiology structure and investments. Anne will work closely with hospital presidents, clinicians, researchers and administrative leadership to guide important systemwide initiatives such as Partners 2.0," Scott Sperling, chair of the Partners board of directors, said in a news release.

Dr. Klibanski received her bachelor's degree in literature from Barnard College and her MD degree from the NYU School of Medicine, both in New York City.

Partners officials said the search for a permanent CEO will take up to one year.

More articles on executive moves:
Geisinger executive to become CMMI senior advisor and medical officer: 4 takeaways
Providence St. Joseph Health names chief people officer: 3 takeaways
Logan Regional Medical Center selects permanent CEO: 4 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.